BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28126470)

  • 1. Ataxia-telangiectasia: Immunodeficiency and survival.
    van Os NJH; Jansen AFM; van Deuren M; Haraldsson A; van Driel NTM; Etzioni A; van der Flier M; Haaxma CA; Morio T; Rawat A; Schoenaker MHD; Soresina A; Taylor AMR; van de Warrenburg BPC; Weemaes CMR; Roeleveld N; Willemsen MAAP
    Clin Immunol; 2017 May; 178():45-55. PubMed ID: 28126470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome.
    Aghamohammadi A; Imai K; Moazzami K; Abolhassani H; Tabatabaeiyan M; Parvaneh N; Nasiri Kalmarzi R; Nakagawa N; Oshima K; Ohara O; Nonoyama S; Rezaei N
    J Investig Allergol Clin Immunol; 2010; 20(5):442-5. PubMed ID: 20945614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
    Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
    Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia.
    Zielen S; Duecker RP; Woelke S; Donath H; Bakhtiar S; Buecker A; Kreyenberg H; Huenecke S; Bader P; Mahlaoui N; Ehl S; El-Helou SM; Pietrucha B; Plebani A; van der Flier M; van Aerde K; Kilic SS; Reda SM; Kostyuchenko L; McDermott E; Galal N; Pignata C; Pérez JLS; Laws HJ; Niehues T; Kutukculer N; Seidel MG; Marques L; Ciznar P; Edgar JDM; Soler-Palacín P; von Bernuth H; Krueger R; Meyts I; Baumann U; Kanariou M; Grimbacher B; Hauck F; Graf D; Granado LIG; Prader S; Reisli I; Slatter M; Rodríguez-Gallego C; Arkwright PD; Bethune C; Deripapa E; Sharapova SO; Lehmberg K; Davies EG; Schuetz C; Kindle G; Schubert R
    J Clin Immunol; 2021 Nov; 41(8):1878-1892. PubMed ID: 34477998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients.
    Amirifar P; Mozdarani H; Yazdani R; Kiaei F; Moeini Shad T; Shahkarami S; Abolhassani H; Delavari S; Sohani M; Rezaei A; Hassanpour G; Akrami SM; Aghamohammadi A
    Immunol Invest; 2021 Feb; 50(2-3):201-215. PubMed ID: 32116070
    [No Abstract]   [Full Text] [Related]  

  • 6. Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms.
    Blanchard-Rohner G; Peirolo A; Coulon L; Korff C; Horvath J; Burkhard PR; Gumy-Pause F; Ranza E; Jandus P; Dibra H; Taylor AMR; Fluss J
    Front Immunol; 2022; 13():791522. PubMed ID: 35154108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas.
    Minto H; Mensah KA; Reynolds PR; Meffre E; Rubtsova K; Gelfand EW
    Clin Immunol; 2019 Mar; 200():55-63. PubMed ID: 30639167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity.
    Driessen GJ; Ijspeert H; Weemaes CM; Haraldsson Á; Trip M; Warris A; van der Flier M; Wulffraat N; Verhagen MM; Taylor MA; van Zelm MC; van Dongen JJ; van Deuren M; van der Burg M
    J Allergy Clin Immunol; 2013 May; 131(5):1367-75.e9. PubMed ID: 23566627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of complete class switching defect in Ataxia telangiectasia patients.
    Ghiasy S; Parvaneh L; Azizi G; Sadri G; Zaki Dizaji M; Abolhassani H; Aghamohammadi A
    Expert Rev Clin Immunol; 2017 May; 13(5):499-505. PubMed ID: 28162005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG subclass pattern in primary immunodeficiency disorders.
    Oxelius VA
    Monogr Allergy; 1986; 19():156-63. PubMed ID: 3762541
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases.
    Ochs HD; Davis SD; Wedgwood RJ
    J Clin Invest; 1971 Dec; 50(12):2559-68. PubMed ID: 5129308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia.
    Micol R; Kayal S; Mahlaoui N; Beauté J; Brosselin P; Dudoit Y; Obenga G; Barlogis V; Aladjidi N; Kebaili K; Thomas C; Dulieu F; Monpoux F; Nové-Josserand R; Pellier I; Lambotte O; Salmon A; Masseau A; Galanaud P; Oksenhendler E; Tabone MD; Teira P; Coignard-Biehler H; Lanternier F; Join-Lambert O; Mouillot G; Theodorou I; Lecron JC; Alyanakian MA; Picard C; Blanche S; Hermine O; Suarez F; Debré M; Lecuit M; Lortholary O; Durandy A; Fischer A
    J Allergy Clin Immunol; 2012 Mar; 129(3):770-7. PubMed ID: 22153772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia?
    Azarsiz E; Karaca NE; Gunaydin NC; Gulez N; Ozturk C; Aksu G; Genel F; Kutukculer N
    Int J Immunopathol Pharmacol; 2014; 27(3):421-7. PubMed ID: 25280033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia telangiectasia presenting as hyper IgM syndrome without neurologic signs.
    Doshi A; Ryu J; Thornburg CD; Hershey D; Cherry R; Milligan K; Rosenzweig S; Leonard S
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):221-6. PubMed ID: 27613453
    [No Abstract]   [Full Text] [Related]  

  • 15. Ataxia Telangiectasia Masquerading as Hyper IgM Syndrome.
    Rawat A; Imai K; Suri D; Gupta A; Bhisikar S; Saikia B; Minz RW; Sehgal S; Singh S
    Indian J Pediatr; 2016 Mar; 83(3):270-1. PubMed ID: 26220245
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative and qualitative investigations of serum IgG subclasses in immunodeficiency diseases.
    Oxelius VA
    Clin Exp Immunol; 1979 Apr; 36(1):112-6. PubMed ID: 466857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia.
    Krauthammer A; Lahad A; Goldberg L; Sarouk I; Weiss B; Somech R; Soudack M; Pessach IM
    BMC Pediatr; 2018 Jun; 18(1):185. PubMed ID: 29866155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ataxia telangiectasia syndrome: clinical picture and immunological abnormalities].
    Pietrucha B; Kmieć T; Mikołuć B; Bernatowska E; Jastrzebska-Piotrowska J; Pac M; Wolska-Kuśnierz B; Kuczyński D
    Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S1-7. PubMed ID: 15045861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM.
    Mohammadinejad P; Abolhassani H; Aghamohammadi A; Pourhamdi S; Ghosh S; Sadeghi B; Nasiri Kalmarzi R; Durandy A; Borkhardt A
    J Immunoassay Immunochem; 2015; 36(1):16-26. PubMed ID: 24568663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan.
    Morio T; Takahashi N; Watanabe F; Honda F; Sato M; Takagi M; Imadome KI; Miyawaki T; Delia D; Nakamura K; Gatti RA; Mizutani S
    Int J Hematol; 2009 Nov; 90(4):455-462. PubMed ID: 19705055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.